Non-alcoholic fatty liver disease (NAFLD) is an emerging public health problem globally. NAFLD one of the most common diseases worldwide and cause abnormal enzymes in many developed countries. estimated to afflict approximately 1 billion individuals worldwide. An 20-30 % general population afflicted from it In India could be a silent epidemic with its prevalence ranging 9-32%. Studies have show...

Alcohol consumption and its abuse are significant prevalent cause for liver diseases and death worldwide. Increased bacterial endotoxin in the portal circulation, the plasma ratio of liver enzymes like alanine aminotransferase (ALT), aspartate aminotransferase (AST) and triglyceride implies the symbiotic relation between the gut and liver plays a key function in alcoholic liver disease (ALD). C...

abstract diabetes is one of the most common metabolic diseases and in the long term affects many parts of body, including liver and kidneys. this study was to investigate alcoholic extract effect of alhagi camelorum on functional tests of liver and kidney in diabetic rats induced by streptozotocin. in this study, 28 wistar male rats were divided into the four groups (n = 7): non-diabetic contro...

AIM OF THE STUDY The aim of the study was to evaluate the effect and severity of liver diseases of different etiologies on the values of three non-invasive fibrosis markers. MATERIAL AND METHODS Serum samples from 65 patients with alcoholic cirrhosis, 31 with non-alcoholic cirrhosis and 32 with toxic hepatitis, were tested. Cirrhotic patients were classified according to the Child-Pugh scale....

Alcoholic liver disease is one of the most prevalent liver diseases worldwide, and a major cause of morbidity and mortality. Alcoholic hepatitis is a severe form of liver injury in patients with alcohol abuse, can present as an acute on chronic liver failure associated with a rapid decline in liver synthetic function, and consequent increase in mortality. Despite therapy, about 30%-50% of patie...

Alcoholic liver disease is an important health problem in the US. A public health approach is proposed, using laboratory tests to identify patients with early fibrosis of the liver. A variety of serological markers of liver fibrosis based on collagen-related products (e.g., amino-terminal propeptides of type III procollagen) have been investigated. Further studies are needed to determine the op...